Tandem Diabetes Care (TNDM) Non-Current Assets (2013 - 2026)

Tandem Diabetes Care's Non-Current Assets history runs 14 years deep, the most recent figure standing at $266.3 million for Q1 2026.

• Quarterly Non-Current Assets rose 2.93% year-over-year to $266.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 15.04% YoY) and the FY2025 annual result came in at $263.0 million, up 8.14% from the prior year.
• Non-Current Assets was $266.3 million for Q1 2026 at Tandem Diabetes Care, up from $263.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $266.3 million in Q1 2026 and bottomed at $181.8 million in Q3 2023.
• A 5-year average of $220.2 million and a median of $204.9 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets jumped 123.66% — and 2023, when it slipped 14.75%.
• Tandem Diabetes Care's Non-Current Assets stood at $202.8 million in 2022, then rose by 0.92% to $204.7 million in 2023, then gained by 18.81% to $243.2 million in 2024, then increased by 8.14% to $263.0 million in 2025, then increased by 1.26% to $266.3 million in 2026.
• Business Quant data shows TNDM's Non-Current Assets at $266.3 million in Q1 2026, $263.0 million in Q4 2025, and $257.7 million in Q3 2025.